William Gann (@gann_will) profile picture

Psychiatrist in Sheffield, UK. Eating disorders. Neuroscience education. Clinical drug trials in mental health. Psychedelic treatments.

Joined April 2018
Photo by William Gann (@gann_will)Photo by William Gann (@gann_will)Photo by William Gann (@gann_will)Photo by William Gann (@gann_will)Photo by William Gann (@gann_will)Photo by William Gann (@gann_will)Photo by William Gann (@gann_will)Photo by William Gann (@gann_will)Photo by William Gann (@gann_will)Photo by William Gann (@gann_will)
Are we excited about psychedelics because we are excited about psychedelics, or are we projecting our dreams onto this field from a place of deep dissatisfaction with existing psychiatry? youtu.be/DV5R9tM4LFw?si=YMky…
1
366
Investigator's meeting in Prague with @COMPASSPathway Guy Goodwin talking about how our study protocol addresses important concerns about placebo/unblinding.
2
204
Ketamine is not a psychedelic. Quite worried to see how many young people are gravitating towards it.
Ketamine is not a psychedelic. It has different subjective effect, pharmacological, toxicity and addiction potential. Please do not conflate.
1
275
Why are we not prioritising intercalated degrees for med students? We are going to lose something important here. 'Doctor as scholar' is 1st outcome? @gmcuk
160
According to dynamical systems, psychiatric disorders can be seen as energy landscapes with peaks and valleys. OCD has deep valleys where neural activity gets stuck, while schizophrenia has shallow valleys that let neural activity roam too freely, connecting unrelated ideas.
340
1,711
694
14,448
1,941,824
Oh my goodness, we won first prize!!! Huge kudos to Bethan who has worked so hard on this project. So important that we listen carefully to our patients as we slowly edge forward in the #psychedelic field. @EllieWildbore @SHSCFT Watch this space for the final write up.
Great day @rcpsychEDFac conference. Extremely proud of the work Bethan Holdsworth is presenting here on the perspectives of ED sufferers on #psychedelics. Many thanks to @EllieWildbore too... strong #PPI vibes all day.
1
4
465
Great day @rcpsychEDFac conference. Extremely proud of the work Bethan Holdsworth is presenting here on the perspectives of ED sufferers on #psychedelics. Many thanks to @EllieWildbore too... strong #PPI vibes all day.
2
1
1,760
Not a script I ever thought I'd write! Some +ve history being made @SHSCFT. Huge effort from whole research/therapy/pharmacy team who all went xtra mile. Massive gratitude to our super brave participant! @jojobuckley @BillyMelton @shrewtbag @allimap14 @MJHorspool #psychedelics
2
3
16
1,981
(disclaimer: Not the real prescription... we wrote this out for fun!)
2
193
Last week I submitted my PhD thesis “The Therapeutic Potential and Mechanisms of Actions of Psilocybin-Assisted Therapy in Anorexia Nervosa Treatment” for examination. Thank you to everyone who has supported me over the last 4 years, I couldn’t have done this without you 🫶 1/?
2
263
IMO there should NEVER be a role for "enforcing" psychedelic treatments in psychiatry. See 1:14:51 below youtu.be/WHPxxVjwy8g?si=tLSY…
1
210
... and I don't think Dr Glover would really support this, if he thought it through. His message was that there is hope for new treatments on the horizon
141
Predictors of this effect included: -Personality trait 'agreeableness' (previously linked to mystical experience on psychedelics) -Frequency of psychedelic use (no surprises there... causality not established) -Setting 'intention' before use -DMT exposure
1
165
The DMT predictor is interesting. This is a short acting psychedelic - could there be a convenience effect here? Easier to incorporate into life/meditation practice?
143